Tangeretin overcomes drug resistance by inhibiting Nrf2 and increases the intracellular accumulation of drugs by inhibiting Nrf2/P-gp, thus making lung cancer cells sensitive to chemotherapy drugs. This evidence concerns the gene NFE2L2 and lung carcinoma.